市場調査レポート
商品コード
1263057

キメラ抗原受容体T細胞(CAR-T)の世界市場レポート2023年

Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2023

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.46円
キメラ抗原受容体T細胞(CAR-T)の世界市場レポート2023年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

世界のキメラ抗原受容体T細胞(CAR-T)市場は、2022年の19億6,000万米ドルから2023年には27億6,000万米ドルに、CAGR40.9%で成長すると予測されています。ロシア・ウクライナ戦争は、少なくとも短期的には、COVID-19パンデミックからの世界経済回復の可能性を混乱させました。この2国間の戦争は、複数の国への経済制裁、商品価格の高騰、サプライチェーンの混乱を招き、商品やサービス全体にインフレを引き起こし、世界中の多くの市場に影響を与えました。キメラ抗原受容体T細胞(CAR-T)市場は、2027年にはCAGR38.8%で102億4,000万米ドルに成長すると予測されます。

2022年のキメラ抗原受容体T細胞(CAR-T)市場では、北米が最大の地域となりました。キメラ抗原受容体T細胞(CAR-T)市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 キメラ抗原受容体T細胞(CAR-T)市場の特徴

第3章 キメラ抗原受容体T細胞(CAR-T)の市場動向と戦略

第4章 キメラ抗原受容体T細胞(CAR-T)市場- マクロ経済シナリオ

  • キメラ抗原受容体T細胞(CAR-T)市場に対するCOVID-19の影響
  • キメラ抗原受容体T細胞(CAR-T)市場に対するウクライナ-ロシア戦争の影響
  • キメラ抗原受容体T細胞(CAR-T)市場に対する高インフレの影響

第5章 キメラ抗原受容体T細胞(CAR-T)の市場規模と成長

  • 世界のキメラ抗原受容体T細胞(CAR-T)市場の実績、2017年から2022年
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のキメラ抗原受容体T細胞(CAR-T)市場の予測、2022-2027F、2032F
    • 市場の促進要因
    • 市場の抑制要因

第6章 キメラ抗原受容体T細胞(CAR-T)市場セグメンテーション

  • 世界のキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • CD19
  • CD22
  • その他の抗原
  • 世界のキメラ抗原受容体T細胞(CAR-T)市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 急性リンパ芽球性白血病
  • びまん性大細胞型B細胞リンパ腫
  • その他のアプリケーション
  • 世界のキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 病院
  • がん研究センター
  • 診療所

第7章 キメラ抗原受容体T細胞(CAR-T)市場の地域および国の分析

  • 世界のキメラ抗原受容体T細胞(CAR-T)市場、地域別、実績と予測、2017-2022、2022-2027F、2032F
  • 世界のキメラ抗原受容体T細胞(CAR-T)市場、国別、実績と予測、2017-2022、2022-2027F、2032F

第8章 アジア太平洋キメラ抗原受容体T細胞(CAR-T)市場

  • アジア太平洋キメラ抗原受容体T細胞(CAR-T)市場概要
  • 地域情報, COVID-19の影響,市場情報,背景情報,政府のイニシアチブ,規制,規制機関,主要団体,課税される税,法人税構造,投資,主要企業
  • アジア太平洋のキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アジア太平洋キメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第9章 中国のキメラ抗原受容体T細胞(CAR-T)市場

  • 中国のキメラ抗原受容体T細胞(CAR-T)市場概要
  • 中国のキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中国のキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第10章 インドのキメラ抗原受容体T細胞(CAR-T)市場

  • インドのキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドのキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第11章 日本のキメラ抗原受容体T細胞(CAR-T)市場

  • 日本のキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 日本のキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第12章 オーストラリアのキメラ抗原受容体T細胞(CAR-T)市場

  • オーストラリアのキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • オーストラリアのキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第13章 インドネシアのキメラ抗原受容体T細胞(CAR-T)市場

  • インドネシアのキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドネシアのキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第14章 韓国のキメラ抗原受容体T細胞(CAR-T)市場

  • 韓国のキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 韓国のキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第15章 西欧のキメラ抗原受容体T細胞(CAR-T)市場

  • 西欧のキメラ抗原受容体T細胞(CAR-T)市場概要
  • 西欧のキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 西欧のキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第16章 英国のキメラ抗原受容体T細胞(CAR-T)市場

  • 英国のキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 英国のキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第17章 ドイツのキメラ抗原受容体T細胞(CAR-T)市場

  • ドイツキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ドイツのキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第18章 フランスのキメラ抗原受容体T細胞(CAR-T)市場

  • フランスキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • フランスのキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第19章 東欧のキメラ抗原受容体T細胞(CAR-T)市場

  • 東欧のキメラ抗原受容体T細胞(CAR-T)市場概要
  • 東欧キメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 東欧のキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第20章 ロシアのキメラ抗原受容体T細胞(CAR-T)市場

  • ロシアのキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ロシアのキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第21章 北米のキメラ抗原受容体T細胞(CAR-T)市場

  • 北米のキメラ抗原受容体T細胞(CAR-T)市場概要
  • 北米のキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 北米のキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第22章 米国のキメラ抗原受容体T細胞(CAR-T)市場

  • 米国のキメラ抗原受容体T細胞(CAR-T)市場概要
  • 米国のキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 米国のキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第23章 南米のキメラ抗原受容体T細胞(CAR-T)市場

  • 南米のキメラ抗原受容体T細胞(CAR-T)市場概要
  • 南米のキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 南米のキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第24章 ブラジルのキメラ抗原受容体T細胞(CAR-T)市場

  • ブラジルのキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ブラジルのキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第25章 中東のキメラ抗原受容体T細胞(CAR-T)市場

  • 中東のキメラ抗原受容体T細胞(CAR-T)市場概要
  • 中東のキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中東キメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第26章 アフリカのキメラ抗原受容体T細胞(CAR-T)市場

  • アフリカキメラ抗原受容体T細胞(CAR-T)市場概要
  • アフリカキメラ抗原受容体T細胞(CAR-T)市場、ターゲット抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アフリカキメラ抗原受容体T細胞(CAR-T)市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第27章 キメラ抗原受容体T細胞(CAR-T)市場の競合情勢と企業プロファイル

  • キメラ抗原受容体T細胞(CAR-T)市場の競合情勢
  • キメラ抗原受容体T細胞(CAR-T)市場の企業プロファイル
    • Novartis International AG
    • Pfizer Inc
    • Gilead Sciences Inc
    • Autolus Therapeutics Plc
    • CARsgen Therapeutics Company Limited

第28章 キメラ抗原受容体T細胞(CAR-T)市場における主要な合併と買収

第29章 キメラ抗原受容体T細胞(CAR-T)市場の将来の見通しと潜在的な分析

第30章 付録

目次
Product Code: r5523

“Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chimeric antigen receptor t (car-t) cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chimeric antigen receptor t (car-t) cells? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The chimeric antigen receptor t (car-t) cells market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Target Antigen: CD19; CD22; Other Antigens
  • 2) By Application: Acute Lymphoblastic Leukaemia; Diffuse Large B-Cell Lymphoma; Other Applications
  • 3) By End User: Hospitals; Cancer Research Centres; Clinics
  • Companies Mentioned: Novartis International AG; Pfizer Inc; Gilead Sciences Inc; Autolus Therapeutics Plc; CARsgen Therapeutics Company Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the chimeric antigen receptor t (car-t) cells market are: Novartis International AG, Pfizer Inc., Gilead Sciences Inc., Autolus Therapeutics Plc, CARsgen Therapeutics Company Limited, Bristol-Myers Squibb Company, Sorrento Therapeutics Inc., Legend Biotech, Mustang Bio Inc., Bluebird Bio Inc., and Eureka Therapeutics Inc.

The global chimeric antigen receptor T (CAR-T) cells market is expected to grow from $1.96 billion in 2022 to $2.76 billion in 2023 at a compound annual growth rate (CAGR) of 40.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chimeric antigen receptor T (CAR-T) cells market is expected to grow to $10.24 billion in 2027 at a CAGR of 38.8%.

The chimeric antigen receptor T (CAR-T) cells market includes revenues earned by entities by providing chimeric antigen receptor T (CAR-T) cells that are used to cure blood cancers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The chimeric antigen receptor T (CAR-T) cells refers to genetically engineered cells that fight with cancer cells to treat the disease. The chimeric antigen receptor T (CAR-T) cells therapy is a form of treatment in which the patient's T cells, a particular type of immune system cell, are altered in a lab so they will target cancer cells. Blood from a patient is drawn to get T cells. Then, in the lab, T cells are given the gene for a unique receptor, chimeric antigen receptor T (CAR-T), that attaches to a particular protein on the patient's cancer cells and helps fight cancer.

North America was the largest region in the chimeric antigen receptor T (CAR-T) cells market in 2022. The regions covered in the chimeric antigen receptor T (CAR-T) cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main target antigens of chimeric antigen receptor T (CAR-T) cells are CD19, CD22, and other antigens. The CD19 antigen refers to use of CAR T-cells for the immunotherapy-based treatment for B-cell acute lymphoblastic leukemia. The application of chimeric antigen receptor T (CAR-T) cells includes acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and other applications that are used in hospitals, cancer research centers, and clinics.

The increasing occurrences of cancer is driving the chimeric antigen receptor T (CAR-T) cells market. Cancer is a chronic disease in which normal body cells divide and grow without any control and affect the nearest body tissue and turn into tumors cells. The chimeric antigen receptor T (CAR-T) cells are used to treat various types of cancers such as hematological malignancies, including acute lymphoblastic leukemia, chronic lymphocytic and can also treat solid tumors such as breast cancer and sarcoma. For instance, in 2021, according to the American Cancer Society, a voluntary health organization, global cancer patients diagnosed is expected to reach 1.9 million in 2021. Due to population increase and age, the worldwide burden of cancer is predicted to reach 27.5 million new cases and 16.2 million cancer deaths by 2040. Therefore, the rising prevalence of cancer disease is anticipated to boost the chimeric antigen receptor T (CAR-T) cells market in the upcoming years.

Product innovation is a key trend gaining popularity in the chimeric antigen receptor T (CAR-T) cells market. Major market players operating in the chimeric antigen receptor T (CAR-T) cells market are concentrating their efforts on creating innovative technologies to develop novel CAR-T cell-based treatments. For instance, in December 2021, Novartis AG, a Switzerland-based pharmaceutical company specializing in the development and manufacturing of drugs launched the T-Charge CAR-T platform. This technology-enabled platform enables the self to renew and maturation CAR-T cells offering a greater proliferative environment for cells.

In November 2021, Laurus Labs, an India-based pharmaceutical and biotechnology company acquired a substantial minority stake (26.62%) in Immunoadoptive Cell Therapy (ImmunoACT) for $5.56 million (INR 0.46 billion). With this acquisition, Laurus Labs will strengthen its biologics business and gains access to an emerging field of research. Immunoadoptive Cell Therapy is an India-based CAR-T cell-therapy company.

The countries covered in the chimeric antigen receptor T (CAR-T) cells market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The chimeric antigen receptor T (CAR-T) market research report is one of a series of new reports from The Business Research Company that provides chimeric antigen receptor T (CAR-T) market statistics, including chimeric antigen receptor T (CAR-T) industry global market size, regional shares, competitors with a chimeric antigen receptor T (CAR-T) market share, detailed chimeric antigen receptor T (CAR-T) market segments, market trends and opportunities, and any further data you may need to thrive in the chimeric antigen receptor T (CAR-T) industry. This chimeric antigen receptor T (CAR-T) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Chimeric Antigen Receptor T (CAR-T) Cells Market Characteristics

3. Chimeric Antigen Receptor T (CAR-T) Cells Market Trends And Strategies

4. Chimeric Antigen Receptor T (CAR-T) Cells Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Chimeric Antigen Receptor T (CAR-T) Cells Market
  • 4.2. Ukraine-Russia War Impact On Chimeric Antigen Receptor T (CAR-T) Cells Market
  • 4.3. Impact Of High Inflation On Chimeric Antigen Receptor T (CAR-T) Cells Market

5. Chimeric Antigen Receptor T (CAR-T) Cells Market Size And Growth

  • 5.1. Global Chimeric Antigen Receptor T (CAR-T) Cells Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Chimeric Antigen Receptor T (CAR-T) Cells Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Chimeric Antigen Receptor T (CAR-T) Cells Market Segmentation

  • 6.1. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • CD19
  • CD22
  • Other Antigens
  • 6.2. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Acute Lymphoblastic Leukaemia
  • Diffuse Large B-Cell Lymphoma
  • Other Applications
  • 6.3. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Cancer Research Centres
  • Clinics

7. Chimeric Antigen Receptor T (CAR-T) Cells Market Regional And Country Analysis

  • 7.1. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 8.1. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 9.1. China Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
  • 9.2. China Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 10.1. India Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 11.1. Japan Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 12.1. Australia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 13.1. Indonesia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 14.1. South Korea Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 15.1. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
  • 15.2. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 16.1. UK Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 17.1. Germany Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 18.1. France Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 19.1. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
  • 19.2. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 20.1. Russia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 21.1. North America Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
  • 21.2. North America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 22.1. USA Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
  • 22.2. USA Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 23.1. South America Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
  • 23.2. South America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 24.1. Brazil Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 25.1. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
  • 25.2. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market

  • 26.1. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
  • 26.2. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Chimeric Antigen Receptor T (CAR-T) Cells Market Competitive Landscape And Company Profiles

  • 27.1. Chimeric Antigen Receptor T (CAR-T) Cells Market Competitive Landscape
  • 27.2. Chimeric Antigen Receptor T (CAR-T) Cells Market Company Profiles
    • 27.2.1. Novartis International AG
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Pfizer Inc
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Gilead Sciences Inc
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Autolus Therapeutics Plc
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. CARsgen Therapeutics Company Limited
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Chimeric Antigen Receptor T (CAR-T) Cells Market

29. Chimeric Antigen Receptor T (CAR-T) Cells Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer